SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Firethorn Wealth Partners LLC

Firethorn Wealth Partners LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,847 shares of the exchange traded fund’s stock after acquiring an additional 769 shares during the quarter. Firethorn Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $797,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of XBI. Avior Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC increased its stake in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth about $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at $49,000.

SPDR S&P Biotech ETF Trading Down 0.6 %

XBI stock opened at $92.46 on Friday. The company has a market cap of $7.05 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average price of $93.34 and a two-hundred day moving average price of $96.88. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.